SBIR Phase II: Development of Integrated Fluid/Solid/Bio-Kinetic Simulation Software for the Characterization of Microsphere-based Bio-analytic Systems

Information

  • NSF Award
  • 0216507
Owner
  • Award Id
    0216507
  • Award Effective Date
    10/1/2002 - 21 years ago
  • Award Expiration Date
    9/30/2004 - 19 years ago
  • Award Amount
    $ 523,948.00
  • Award Instrument
    Standard Grant

SBIR Phase II: Development of Integrated Fluid/Solid/Bio-Kinetic Simulation Software for the Characterization of Microsphere-based Bio-analytic Systems

This Small Business Innovation Research (SBIR) Phase II project will develop and customize advanced simulation software for the design and optimization of microsphere and cell-based assays. Current assay design by trial and error is slow, unreliable, expensive, and a bottleneck for multiplexed, high-throughput analysis. Prior Phase I research has successfully established a first-ever, truly integrated (buffer flow, resolved microsphere motion and surface biochemistry) assay design and analysis tool. The objective of the Phase II effort is to further develop the initial models demonstrated in the Phase I effort into a comprehensive, generalized design environment. A suite of bead-surface biochemistry models (enzyme kinetics, multi-step reactions) and including user specifiable surface reaction mechanisms will be developed and fully integrated. In seeking to expand the application to cell-based assays, models for the motion and capture of deformable cells will be created, and detailed flow visualization experiments tracking bead and cell motion as well as assay endpoints in microfluidic channels will be conducted to guide and validate these models. The value of the developed simulation tool will be demonstrated in the proof-of-concept design of a novel microfluidic, cell-based H-filter assay for red-blood cell based aminothiols.<br/><br/>The commercial applications of this project will be in the biotechnology and bioassay design markets. Miniaturized, multiplexed, high-throughput, fast, efficient and sensitive assays are a pre-requisite to translating the wealth of data from the human genome and combinatorial libraries into effective therapeutics. The developed software product will enable rational, computer-based design of these bioassays.

  • Program Officer
    Om P. Sahai
  • Min Amd Letter Date
    9/17/2002 - 21 years ago
  • Max Amd Letter Date
    6/21/2004 - 19 years ago
  • ARRA Amount

Institutions

  • Name
    CFD RESEARCH CORPORATION
  • City
    HUNTSVILLE
  • State
    AL
  • Country
    United States
  • Address
    701 McMillian Way NW, Suite D
  • Postal Code
    358062923
  • Phone Number
    2567264800

Investigators

  • First Name
    Shivshankar
  • Last Name
    Sundaram
  • Email Address
    jls@cfdrc.com
  • Start Date
    9/17/2002 12:00:00 AM

FOA Information

  • Name
    Industrial Technology
  • Code
    308000

Program Element

  • Text
    SMALL BUSINESS PHASE II
  • Code
    5373

Program Reference

  • Text
    EXP PROG TO STIM COMP RES
  • Code
    9150
  • Text
    BIOPROCESSING/BIOMOLECULAR MATERIALS
  • Code
    9181
  • Text
    BIOTECHNOLOGY
  • Text
    UNDERGRADUATE EDUCATION
  • Code
    9178
  • Text
    RES EXPER FOR UNDERGRAD-SUPPLT
  • Code
    9251